514
H.-Y. Mao, H. Song, and D.-Q. Shi
Vol 49
General procedure for the synthesis of (Z)-1-tert-butyl
(or phenyl)-2-(1H-1,2,4-triazol-1-yl)-ethanone oximes 3 or
(1Z, 3Z)-4,4-dimethyl-1-substitutedphenyl-2-(1H-1,2,4-triazol-
temperature for 10–12 h till the reaction was complete
(monitored by TLC). The workup involved washing with
water and 5% NaHCO3, respectively. After phase separation,
drying over anhydrous sodium sulphate, filtration, and
evaporation, the crude product was purified by column
chromatography on silica gel using petroleum ether and
acetone (3:1 v/v) as the eluent, giving the target compounds 5
and 6 in 65–84% yields.
1-yl)-pent-1-en-3-one oximes 4.
To the stirred mixture of
1 or 2 (12.8 mmol), K2CO3 (2.33 g, 16.9 mmol) in anhydrous
methanol (20 mL) and hydroxylamine hydrochloride (1.08 g,
15.4 mmol) in H2O (6 mL) were added slowly at 0ꢂ5ꢁC. After
the addition completed, the solution was stirring under reflux for
8–10 h. The mixture was concentrated under vacuum, the
residue was poured to water (10 mL). The solid was collected
by filtration, and recrystallized from the mixture of methanol
and petroleum ether (V/V 1:1) to get 3 and 4 as a white solid.
Data for 5a (R = t-Bu): light yellow solid, yield: 65%, m.p.
129.5–130.6ꢁC; IR: C¼O 1742, C¼N 1526, 1506, C—O 1250,
1048, N—O—C 1033; 1H NMR (600 MHz, CDCl3): d 1.32(s, 9H,
t-Bu), 2.69 (s, 3H, CH3), 2.71 (s, 3H, CH3), 5.10 (s, 2H, CH2),
7.95 (s, 1H, triazole-H), 8.15 (s, 1H, triazole-H); ESI-MS:
m/z 343.5 (M+Na, 100), 322 (M+1, 5). Anal. Calcd for
C14H19N5O2S: C, 52.32; H, 5.96; N, 21.79. Found: C, 52.37; H,
5.71; N, 21.94.
Data for 5b (R = Ph): light yellow crystals, yield: 77%, m.p.
113.5–114.8ꢁC; IR: Ph-H 3098, 2961, C¼O 1754, Ph 1660,
1449, C¼N 1519, 1314, C—O 1244, 1194, N—O—C 1019;
1H NMR (600 MHz, CDCl3): d 2.75 (s, 3H, CH3), 2.78 (s, 3H,
CH3), 5.58 (s, 2H, CH2), 7.43–7.46 (m, 2H, ArH), 7.49–7.50
(m, 1H, ArH), 7.84 (d, J = 7.2 Hz, 2H, ArH), 7.95 (s, 1H, tria-
zole-H), 8.20 (s, 1H, triazole-H); ESI-MS: m/z 364 (M+Na,
100). Anal. Calcd for C16H15N5O2S: C, 56.29; H, 4.43; N,
20.51. Found: C, 56.05; H, 4.34; N, 20.30.
3,3-Dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-one oxime
1
(3a). White solid, yield: 89%, m.p. 123.4–124.7 ꢁC; H NMR
(CDCl3, 400 MHz): d 1.17 (s, 9H, t-Bu), 5.05 (s, 2H, CH2),
7.91 (s, 1H, triazole-H), 8.31 (s, 1H, triazole-H), 9.41 (s, 1H,
OH). Anal. Calcd for C8H14N4O: C, 52.73; H, 7.74; N, 30.75.
Found: C, 52.57; H, 7.61; N, 30.53.
1-(Phenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone oxime (3b).
1
White solid, yield: 82%, m.p. 153.3–155.4ꢁC; H NMR (CDCl3,
400 MHz): d 5.56 (s, 2H, CH2), 7.42–7.81 (m, 5H, ArH), 7.93
(s, 1H, triazole-H), 8.16 (s, 1H, triazole-H), 9.38 (s, 1H, OH).
Anal. Calcd for C10H10N4O: C, 59.40; H, 4.98; N, 27.71. Found:
C, 59.25; H, 5.14; N, 27.90.
(1Z, 3Z)-1-(2,4-Dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-
Data for 5c (R = t-Bu): yellow solid, yield: 82%, m.p.
70.6–72.4ꢁC; IR: C¼O 1751, C¼N 1533, 1496, C—O 1245,
1052, N—O—C 1030; 1H NMR (600 MHz, CDCl3): d 1.36
(s, 9H, t-Bu), 2.98 (s, 3H, CH3), 5.12 (s, 2H, CH2), 7.95 (s, 1H,
triazole-H), 8.15 (s, 1H, triazole-H); ESI-MS: m/z 330.6
(M+Na, 100), 328 (48), 183 (55). Anal. Calcd for C12H16N6O2S:
C, 46.74; H, 5.23; N, 27.25. Found: C, 46.96; H, 5.28; N, 27.17.
triazol-1-yl)pent-1-en-3-one oxime (4a).
White solid, yield:
1
70%, m.p. 147.6–148.7ꢁC; H NMR (CDCl3, 400 MHz): d 1.17
(s, 9H, t-Bu), 6.36 (d, J = 9.0 Hz, 1H, ArH), 7.19 (d, J = 9.0 Hz,
1H, ArH), 7.45 (s, 1H, ArH), 7.48 (s, 1H, ¼CH), 7.89 (s, 1H,
triazole-H), 8.23 (s, 1H, triazole-H), 9.42 (s, 1H, OH). Anal.
Calcd for C15H16Cl2N4O: C, 53.11; H, 4.75; N, 16.52. Found:
C, 53.27; H, 4.78; N, 16.63.
Data for 6a (Ar = 4-ClC6H4): yellow crystals, yield: 84%, m.p.
133.0–133.8ꢁC; IR: Ph-H 3095, 2938, C¼O 1754, Ph 1588,
1485, 1433, C¼N 1510, C—O 1203, 1024, N—O—C 1001;
1H NMR (600 MHz, CDCl3): d 1.62 (s, 9H, t-Bu), 2.74 (s, 3H,
CH3), 2.78 (s, 3H, CH3), 7.36 (d, J = 8.4 Hz, 2H, ArH), 7.67
(s, 1H, ¼CH), 7.73 (d, J = 8.4 Hz, 2H, ArH), 8.10 (s, 1H,
triazole-H), 8.44 (s, 1H, triazole-H); ESI-MS: m/z 443
(M+, 100). Anal. Calcd for C21H22ClN5O2S: C, 56.81; H, 4.99;
N, 15.78. Found: C, 56.64; H, 5.07; N, 16.02.
(1Z, 3Z)-4,4-Dimethyl-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-
1-yl)pent-1-en-3-one oxime (4b).
White solid, yield: 65%,
m.p. 119.5–120.5ꢁC; 1H NMR (CDCl3, 400 MHz): d 1.18
(s, 9H, t-Bu), 7.34 (d, J = 8.0 Hz, 2H, ArH), 7.50 (d, J = 8.0 Hz,
2H, ArH), 7.61 (s, 1H, ¼CH), 7.92 (s, 1H, triazole-H), 8.33
(s, 1H, triazole-H), 10.11 (s, 1H, OH). Anal. Calcd for
C15H17ClN4O: C, 59.11; H, 5.62; N, 18.38. Found: C, 59.02;
H, 5.49; N, 18.30.
(1Z, 3Z)-1-(4-Methoxyphenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-
Data for 6b (Ar = 2,4-Cl2C6H3): yellow crystals, yield:
75%, m.p. 117.5–118.4ꢁC; IR: Ph-H 3074, 2915, C¼O
1751, Ph 1545, 1438, 1407, C¼N 1524, C—O 1235, 1026,
N—O—C 1013; 1H NMR (600 MHz, CDCl3): d 1.59
(s, 9H, t-Bu), 2.74 (s, 3H, CH3), 2.79 (s, 3H, CH3), 7.27
(s, 1H, ¼CH), 7.29 (s, 1H, triazole-H), 7.34 (d, J = 9.0 Hz,
1H, ArH), 7.48 (s, 1H, ArH), 8.10 (d, J = 9.0 Hz, 1H,
ArH), 8.83 (s, 1H, triazole-H); ESI-MS: m/z 518 (M+K+2,
100), 516 (M+K, 78), 498 (M+Naꢀ1, 63). Anal. Calcd for
C21H21Cl2N5O2S: C, 52.72; H, 4.42; N, 14.64. Found: C,
52.59; H, 4.50; N, 14.71.
Data for 6c (Ar = 4-ClC6H4): yellow solid, yield: 73%, m.p.
131.1–133.3ꢁC; IR: Ph-H 3076, 2905, C¼O 1742, Ph 1562,
1465, 1372, C¼N 1524, C—O 1218, 1026, N—O—C 1017;
1H NMR (600 MHz, CDCl3): d 1.18 (s, 9H, t-Bu), 3.07 (s, 3H,
CH3), 7.47 (d, J = 8.4 Hz, 2H, ArH), 7.74 (d, J = 9.0 Hz, 2H,
ArH), 7.88 (s, 1H, ¼CH), 8.26 (s, 1H, triazole-H), 8.49 (s, 1H,
triazole-H); ESI-MS: m/z 452 (M+Naꢀ1, 15), 430.5 (M+, 100).
Anal. Calcd for C19H19ClN6O2S: C, 52.96; H, 4.44; N, 19.50.
Found: C, 52.73; H, 4.53; N, 19.37.
1-yl)pent-1-en-3-one oxime (4c).
White solid, yield: 79%,
m.p. 121.3–122.4ꢁC; 1H NMR (CDCl3, 400 MHz): d 1.19 (s, 9H,
t-Bu), 3.86 (s, 3H, OCH3), 6.97 (d, J = 7.6 Hz, 2H, ArH), 7.75
(d, J = 7.2 Hz, 2H, ArH), 7.83 (s, 1H, ¼CH), 7.91 (s, 1H,
triazole-H), 8.38 (s, 1H, triazole-H), 10.05 (s, 1H, OH).
Anal. Calcd for C16H20N4O2: C, 63.98; H, 6.71; N, 18.65.
Found: C, 63.83; H, 6.54; N, 18.77.
General procedure for the synthesis of (Z)-1-tert-butyl (or
phenyl)-2-(1H-1,2,4-triazol-1-yl)-ethanone O-[2,4-dimethylthiazole
(or 4-methyl-1,2,3-thiadiazole)-5-carbonyl] oximes 5 and
(1Z, 3Z)-4,4-dimethyl-1-substitutedphenyl-2-(1H-1,2,4-triazol-
1-yl)-pent-1-en-3-one O-[2,4-dimethylthiazole (or 4-methyl-
1,2,3-thiadiazole)-5-carbonyl] oximes 6.
Oxime 3 or 4
(2.0 mmol), triethylamine (2.4 mmol) and anhydrous chloroform
(7.5 mL) were added to a three-necked flask, a solution of
2,4-dimethylthiazole-5-carbonyl chloride [or 4-methyl-1,2,3-
thiadiazole)-5-carbonyl chloride] (2.2 mmol) in anhydrous
chloroform (5 mL) was added dropwise slowly at 5–10ꢁC.
After the addition completed, the mixture was stirred at room
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet